Mr Arvil Boler Miller, CRNA | |
809 University Blvd E, -, Tuscaloosa, AL 35401-2029 | |
(205) 759-7111 | |
Not Available |
Full Name | Mr Arvil Boler Miller |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 41 Years |
Location | 809 University Blvd E, Tuscaloosa, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114955218 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 1-035494 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dch Medical Center Crna | 5395933626 | 33 |
News Archive
Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent-significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that IBC usually grows rapidly and often spreads quickly to other parts of the body, including the brain, bone and lymph nodes.
Researchers in the United States have demonstrated the effectiveness of messenger RNA (mRNA)-based vaccination at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among almost 47,000 healthcare workers.
BRCA1 and BRCA2 genes are two of the most well studied genes in the cancer field. They are tumor suppressors - mutations in these genes can lead to breast and/or ovarian cancer. Predispositions can be detected in women before they develop cancer.
Bristol-Myers Squibb Company today announced that a clinical trial - known as study 024 - of its investigational compound ipilimumab has met the primary endpoint of improving overall survival in previously-untreated patients with metastatic melanoma.
Nutricia North America, a manufacturer of medical foods and specialized infant formulas such as NeocateĀ®, announced today that it has begun packaging its powdered medical foods and specialized infant formulas in cans with BPA-free lining.
› Verified 2 days ago
Entity Name | Dch Medical Center Crna |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356642045 PECOS PAC ID: 5395933626 Enrollment ID: O20101230000396 |
News Archive
Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent-significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that IBC usually grows rapidly and often spreads quickly to other parts of the body, including the brain, bone and lymph nodes.
Researchers in the United States have demonstrated the effectiveness of messenger RNA (mRNA)-based vaccination at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among almost 47,000 healthcare workers.
BRCA1 and BRCA2 genes are two of the most well studied genes in the cancer field. They are tumor suppressors - mutations in these genes can lead to breast and/or ovarian cancer. Predispositions can be detected in women before they develop cancer.
Bristol-Myers Squibb Company today announced that a clinical trial - known as study 024 - of its investigational compound ipilimumab has met the primary endpoint of improving overall survival in previously-untreated patients with metastatic melanoma.
Nutricia North America, a manufacturer of medical foods and specialized infant formulas such as NeocateĀ®, announced today that it has begun packaging its powdered medical foods and specialized infant formulas in cans with BPA-free lining.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Arvil Boler Miller, CRNA 16065 Carmel Bay Dr, Northport, AL 35475-4002 Ph: (205) 333-7003 | Mr Arvil Boler Miller, CRNA 809 University Blvd E, -, Tuscaloosa, AL 35401-2029 Ph: (205) 759-7111 |
News Archive
Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent-significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that IBC usually grows rapidly and often spreads quickly to other parts of the body, including the brain, bone and lymph nodes.
Researchers in the United States have demonstrated the effectiveness of messenger RNA (mRNA)-based vaccination at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among almost 47,000 healthcare workers.
BRCA1 and BRCA2 genes are two of the most well studied genes in the cancer field. They are tumor suppressors - mutations in these genes can lead to breast and/or ovarian cancer. Predispositions can be detected in women before they develop cancer.
Bristol-Myers Squibb Company today announced that a clinical trial - known as study 024 - of its investigational compound ipilimumab has met the primary endpoint of improving overall survival in previously-untreated patients with metastatic melanoma.
Nutricia North America, a manufacturer of medical foods and specialized infant formulas such as NeocateĀ®, announced today that it has begun packaging its powdered medical foods and specialized infant formulas in cans with BPA-free lining.
› Verified 2 days ago
Tonya Via, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7755 | |
Mr. Joseph Lee Stork Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 | |
Soon Ja Stanley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7352 Fax: 205-759-6397 | |
Melissa Newell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-5500 Fax: 205-502-5152 | |
Lisa J. Pennington, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-5500 Fax: 205-502-5152 | |
Laura Carter Foster, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 |